ArticleCancers2026

Trifluridine/Tipiracil Plus Bevacizumab Versus Regorafenib in Elderly Patients with Refractory Metastatic Colorectal Cancer: A Real-World Comparative Study.

Yu-Kang Tseng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.